Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Total Non-Current Liabilities (2016 - 2026)

Champions Oncology has reported Total Non-Current Liabilities over the past 16 years, most recently at $24.0 million for Q1 2026.

  • Quarterly results put Total Non-Current Liabilities at $24.0 million for Q1 2026, down 3.34% from a year ago — trailing twelve months through Jan 2026 was $24.0 million (down 3.34% YoY), and the annual figure for FY2025 was $28.5 million, up 3.09%.
  • Total Non-Current Liabilities for Q1 2026 was $24.0 million at Champions Oncology, down from $25.9 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for CSBR hit a ceiling of $29.1 million in Q2 2023 and a floor of $24.0 million in Q1 2026.
  • Median Total Non-Current Liabilities over the past 5 years was $26.6 million (2022), compared with a mean of $26.4 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 41.92% in 2022 and later decreased 12.59% in 2024.
  • Champions Oncology's Total Non-Current Liabilities stood at $26.6 million in 2022, then grew by 4.35% to $27.7 million in 2023, then decreased by 12.59% to $24.2 million in 2024, then increased by 6.81% to $25.9 million in 2025, then decreased by 7.12% to $24.0 million in 2026.
  • The last three reported values for Total Non-Current Liabilities were $24.0 million (Q1 2026), $25.9 million (Q4 2025), and $26.9 million (Q3 2025) per Business Quant data.